AI-generated summary
The authors report a prospective single-center study of 17 women with facial hyperpigmentation treated with a dual-wavelength laser in up to three sessions. Investigator assessments showed improvements in hyperpigmentation and skin quality at follow-up in most patients, with transient side effects such as erythema. Safety and efficacy are described from a small, open-label study without a control group.
- Participants
- 17
- Who or what was studied
- 17 healthy women with facial hyperpigmentation, mean age 43.4 years (SD 11.6), skin phototypes II-IV
- Wavelengths
- 589, 1319 nm
- Limits stated in the abstract
- The study is small, single-center, open-label and uncontrolled, and outcomes relied on investigator ratings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jddonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1319 nm, 1319nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Wavelength, Laser, Digital object identifier, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.